ChemPartner PharmaTech Co., a leading player in the pharmaceutical and biotechnology sectors, is headquartered in China (CN) and operates extensively across Asia, Europe, and North America. Founded in 2003, the company has established itself as a trusted partner in drug discovery, development, and manufacturing services, catering to a diverse clientele in the life sciences industry. With a robust portfolio that includes integrated drug discovery, preclinical development, and clinical trial services, ChemPartner stands out for its commitment to innovation and quality. The company’s state-of-the-art facilities and experienced team enable it to deliver tailored solutions that accelerate the drug development process. Recognised for its scientific expertise and operational excellence, ChemPartner has achieved significant milestones, solidifying its position as a preferred partner for pharmaceutical companies worldwide.
How does ChemPartner PharmaTech Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ChemPartner PharmaTech Co's score of 27 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, ChemPartner PharmaTech Co, headquartered in CN, reported total carbon emissions of approximately 13,354,090 kg CO2e. Notably, the company disclosed emissions solely from Scope 3, amounting to about 1,597,160 kg CO2e. There is currently no available data on Scope 1 and Scope 2 emissions. Despite the significant total emissions, ChemPartner PharmaTech Co has not established specific reduction targets or initiatives, nor have they committed to any climate pledges. The absence of such commitments may reflect a broader industry context where many companies are still developing their climate strategies. As of now, ChemPartner PharmaTech Co does not inherit emissions data from any parent or related organizations, indicating that their reported figures are solely based on their own operations.
Access structured emissions data, company-specific emission factors, and source documents
2022 | |
---|---|
Scope 1 | - |
Scope 2 | - |
Scope 3 | 1,597,160 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ChemPartner PharmaTech Co is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.